174 related articles for article (PubMed ID: 35347540)
1. Clinical use of Anti-Müllerian Hormone to monitor resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queens.
Ferré-Dolcet L; Ferro S; Contiero B; Fontaine C; Badon T; Gelli D; Romagnoli S
Vet Res Commun; 2022 Sep; 46(3):917-924. PubMed ID: 35347540
[TBL] [Abstract][Full Text] [Related]
2. Resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queens.
Ferré-Dolcet L; Ferro S; Contiero B; Andretta F; Cattai A; Fontaine C; Romagnoli S
Reprod Domest Anim; 2022 Jan; 57(1):3-9. PubMed ID: 34610192
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian Hormone Concentrations for Determining Resumption of Sertoli Cell Function following Removal of a 4.7 mg Deslorelin Implant in Tomcats.
Ferré-Dolcet L; Bordogna M; Contiero B; Fontaine C; Bedin S; Romagnoli S
Animals (Basel); 2023 Aug; 13(16):. PubMed ID: 37627341
[No Abstract] [Full Text] [Related]
4. Postponement of puberty in queens treated with deslorelin.
Cecchetto M; Salata P; Baldan A; Milani C; Mollo A; Fontaine C; Sontas H; Gelli D; De Benedictis G; Stelletta C; Romagnoli S
J Feline Med Surg; 2017 Dec; 19(12):1224-1230. PubMed ID: 28195504
[TBL] [Abstract][Full Text] [Related]
5. Effects of the GnRH analogue deslorelin implants on reproduction in female domestic cats.
Toydemir TS; Kılıçarslan MR; Olgaç V
Theriogenology; 2012 Feb; 77(3):662-74. PubMed ID: 22015158
[TBL] [Abstract][Full Text] [Related]
6. Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens.
Ackermann CL; Volpato R; Destro FC; Trevisol E; Sousa NR; Guaitolini CR; Derussi AA; Rascado TS; Lopes MD
Theriogenology; 2012 Sep; 78(4):817-22. PubMed ID: 22578612
[TBL] [Abstract][Full Text] [Related]
7. Reproductive performance of early postpartum Holstein cows where oestrus was synchronised following chronic GnRH agonist treatment.
Padula AM; MacMillan KL
Aust Vet J; 2005 Mar; 83(3):163-7. PubMed ID: 15825629
[TBL] [Abstract][Full Text] [Related]
8. Length of efficacy and effect of implant location in adult tom cats treated with a 9.4 mg deslorelin subcutaneous implant.
Romagnoli S; Baldan A; Ferro S; Righetti C; Scenna L; Gabai G; Badon T; Fontaine C; Mollo A; Stelletta C; Milani C
J Feline Med Surg; 2019 Jun; 21(6):507-519. PubMed ID: 30056772
[TBL] [Abstract][Full Text] [Related]
9. Restoration patterns for luteinising hormone and ovarian function following treatment with GnRH agonist implants (deslorelin) for 7, 14 or 21 days in cycling dairy cows.
Padula AM; Macmillan KL
Anim Reprod Sci; 2005 Jun; 87(1-2):11-24. PubMed ID: 15885437
[TBL] [Abstract][Full Text] [Related]
10. Age-associated and deslorelin-induced declines in serum anti-Müllerian hormone concentrations in female cheetahs, Acinonyx jubatus.
Place NJ; Crosier AE; Comizzoli P; Nagashima JB; Haefele H; Schmidt-Küntzel A; Marker LL
Gen Comp Endocrinol; 2017 Sep; 250():54-57. PubMed ID: 28602789
[TBL] [Abstract][Full Text] [Related]
11. Treatment of queens in estrus and after estrus with a GnRH-agonist implant containing 4.7 mg deslorelin; hormonal response, duration of efficacy, and reversibility.
Goericke-Pesch S; Georgiev P; Atanasov A; Albouy M; Navarro C; Wehrend A
Theriogenology; 2013 Mar; 79(4):640-6. PubMed ID: 23265930
[TBL] [Abstract][Full Text] [Related]
12. Reproductive responses of early postpartum dairy cattle to continuous treatment with a GnRH agonist (deslorelin) for 28 days to delay the resumption of ovulation.
Padula AM; Macmillan KL
Anim Reprod Sci; 2002 Mar; 70(1-2):23-36. PubMed ID: 11841904
[TBL] [Abstract][Full Text] [Related]
13. Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares.
Johnson CA; Thompson DL; Cartmill JA
J Anim Sci; 2003 May; 81(5):1300-7. PubMed ID: 12772858
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic examination of the genital tract in rabbits treated once or twice with a slow-release deslorelin implant for reversible suppression of ovarian function.
Geyer A; Poth T; Otzdorff C; Daub L; Reese S; Braun J; Walter B
Theriogenology; 2016 Dec; 86(9):2281-2289. PubMed ID: 27667750
[TBL] [Abstract][Full Text] [Related]
15. Semen quality and interval to sterility in tom cats treated with a 9.4 mg deslorelin implant.
Romagnoli S; Baldan A; Righetti C; Milani C; Mollo A; Stelletta C
J Feline Med Surg; 2017 Feb; 19(2):194-199. PubMed ID: 26763267
[TBL] [Abstract][Full Text] [Related]
16. Contraceptive implants used by cat breeders in France: a study of 140 purebred cats.
Furthner E; Roos J; Niewiadomska Z; Maenhoudt C; Fontbonne A
J Feline Med Surg; 2020 Oct; 22(10):984-992. PubMed ID: 32081074
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone concentrations in queens throughout the estrous cycle.
Flock U; Reese S; Otzdorff C; Klein R; Walter B
Domest Anim Endocrinol; 2022 Oct; 81():106749. PubMed ID: 35834880
[TBL] [Abstract][Full Text] [Related]
18. Effects of implants containing the GnRH agonist deslorelin on testosterone release and semen characteristics in Shetland stallions.
Gautier C; Schmidt K; Aurich J; Aurich C
Anim Reprod Sci; 2018 Aug; 195():230-241. PubMed ID: 29859702
[TBL] [Abstract][Full Text] [Related]
19. Anti-Müllerian hormone, testosterone, and insulin-like peptide 3 as biomarkers of Sertoli and Leydig cell function during deslorelin-induced testicular downregulation in the dog.
Balogh O; Somoskői B; Kollár E; Kowalewski MP; Gram A; Reichler IM; Klein R; Kawate N; Mester L; Walter B; Müller L
Theriogenology; 2021 Nov; 175():100-110. PubMed ID: 34534687
[TBL] [Abstract][Full Text] [Related]
20. Interval between Removal of a 4.7 mg Deslorelin Implant after a 3-, 6-, and 9-Month Treatment and Restoration of Testicular Function in Tomcats.
Ferré-Dolcet L; Carniello L; Ferro S; Cattai A; Romagnoli S; Mollo A
Animals (Basel); 2020 Sep; 10(9):. PubMed ID: 32887474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
